Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 9/20 | 0.43 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | MANBA | O00462 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13415299 | 1.00 | SLC5A2 (0.43) | SLC5A2SLC5A1EPHX1MANBA | |
| SCHEMBL27526484 | 0.86 | SLC5A2 (0.38) | SLC5A2SLC5A1 | |
| SCHEMBL28928268 | 0.86 | EPHX1 (0.35) | SLC5A2SLC5A1EPHX1 | |
| SCHEMBL28774531 | 0.86 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL28649385 | 0.85 | SLC5A2 (0.39) | SLC5A2SLC5A1 | |
| SCHEMBL20373569 | 0.85 | EPHX1 (0.34) | SLC5A2SLC5A1EPHX1MANBA | |
| SCHEMBL7681079 | 0.83 | SLC5A2 (0.49) | SLC5A2SLC5A1 | |
| SCHEMBL9809746 | 0.83 | SLC5A2 (0.37) | SLC5A2 | |
| SCHEMBL28650376 | 0.82 | SLC5A2 (0.49) | SLC5A2SLC5A1 | |
| SCHEMBL27554109 | 0.82 | SLC5A2 (0.38) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8231884-B2 | Polymer or surfactant enveloping oriented fibers; mass formed by 3:2,4-di-O-benzylidene-D-sorbitol organogelator; oblong particles have beneficial iridescent properties; soft-focus effect properties; make-up and foundation improve visual appearance of skin | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-07-31 | — | — | US | claimed |
| US-20080248071-A1 | Diffusing Particles Based on Organogelling Xerogel Fibers, Method for Preparing Same and Use in Cosmetic Formulations | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2008-10-09 | — | — | US | claimed |
| US-11697735-B2 | Solid oleaginous compositions | TOTAL MARKETING SERVICES (FR) | 2023-07-11 | — | — | US | disclosed |
| US-11365317-B2 | Solid binders | TOTAL MARKETING SERVICES (FR) | 2022-06-21 | — | — | US | disclosed |
| EP-3612616-B1 | SOLID BITUMEN AT AMBIENT TEMPERATURE | TOTAL MARKETING SERVICES (FR) | 2022-06-01 | — | — | EP | disclosed |
| US-11332606-B2 | Clear binder that is solid when cold | TOTAL MARKETING SERVICES (FR) | 2022-05-17 | — | — | US | disclosed |
| CN-110050035-B | Solid oleaginous compositions | 道达尔销售服务公司 | 2022-05-13 | — | — | CN | disclosed |
| US-20220145079-A1 | BITUMINOUS COMPOSITION SOLID AT AMBIENT TEMPERATURE | TOTAL MARKETING SERVICES (FR) | 2022-05-12 | — | — | US | disclosed |
| EP-3510103-B1 | CLEAR SOLID COLD BINDER | TOTAL MARKETING SERVICES (FR) | 2022-02-16 | — | — | EP | disclosed |
| US-11242287-B2 | Bitumen which is solid at ambient temperature | TOTAL MARKETING SERVICES (FR) | 2022-02-08 | — | — | US | disclosed |
| US-11198105-B2 | Method for manufacturing material in the form of granules that can be used as road binder or sealing binder and device for manufacturing same | TOTAL MARKETING SERVICES (FR) | 2021-12-14 | — | — | US | disclosed |
| EP-1778709-B1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RES INST LTD (HU) | 2008-05-28 | — | — | EP | disclosed |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2007-12-06 | — | — | US | disclosed |
| WO-2007098597-A1 | GLYCOSIDASE INHIBITORS AND METHODS OF SYNTHESIZING SAME | SIMON FRASER UNIVERSITY (CA) | 2007-09-07 | — | — | WO | disclosed |
| WO-2007098597-A1 | GLYCOSIDASE INHIBITORS AND METHODS OF SYNTHESIZING SAME | SIMON FRASER UNIVERSITY (CA) | 2007-09-07 | — | — | WO | disclosed |
| EP-1778709-A2 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX Drug Research Institute Ltd (HU) | 2007-05-02 | — | — | EP | disclosed |
| WO-2007039561-A1 | DIFFUSING PARTICLES BASED ON ORGANOGELLING XEROGEL FIBERS, METHOD FOR PREPARING SAME AND USE IN COSMETIC FORMULATIONS | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2007-04-12 | — | — | WO | disclosed |
| CN-1303076-C | Asymmetric benzaldehyde alditol derivatives, methods of making thereof, and compositions and articles containing same | MILLIKEN & CO (US) | 2007-03-07 | — | — | CN | disclosed |
| US-20060247222-A1 | Glycosidase inhibitors and methods of synthesizing same | SIMON FRASER UNIVERSITY (CA) | 2006-11-02 | — | — | US | disclosed |
| WO-2006017726-A2 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RESEARCH INSTITUTE LTD (HU) | 2006-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248071-A1 | Diffusing Particles Based on Organogelling Xerogel Fibers, Method for Preparing Same and Use in Cosmetic Formulations | SORD, DPM1, SUCLG1 | SLC5A2 1924/4885SLC5A1 2916/4885EPHX1 4528/4885 |
| US-20060247222-A1 | Glycosidase inhibitors and methods of synthesizing same | STS, SCLY, MGAM | SLC5A2 12/4885SLC5A1 19/4885EPHX1 1200/4885 |
| US-20070281893-A1 | Polysulfated Glycosides And Salts Thereof | CFTR, AREG, STS | SLC5A2 292/4885SLC5A1 195/4885EPHX1 2360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.